|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.10 HKD | -0.18% |
|
+3.38% | +57.34% |
| 06-05 | Keymed Biosciences Receives $257 Million Upfront Payment After Gilead-Ouro Deal Close | MT |
| 06-04 | Lakefront Biotherapeutics, Gilead Complete Ouro Acquisition for $1.68 Billion Upfront | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 86.85 | 86.85 | 94.53 |
| Spread/Res. | -3.17% | -3.17% | -11.03% |
| Spread/Supp. | +18.87% | +36.08% | +30.19% |
| Support | 70.75 | 61.8 | 64.6 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 2162 Stock
- Charts Keymed Biosciences Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
